1. 127 Impact of CYP2D6, CYP3A4, and CYP2C9 pharmacogenomic profile on pain relief and adverse events in Canadian children treated with oxycodone and ibuprofen. (29th October 2021) Authors: Yukseloglu, Aran; Ali, Samina; Drendel, Amy; Carleton, Bruce; Ross, Colin; Le May, Sylvie; Manaloor, Robin; Rosychuk, Rhonda; Johnson, David Journal: Paediatrics & Child Health Issue: Volume 26: Supplement 1(2021) Page Start: e90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mechanisms of lysophosphatidylcholine‐induced demyelination: A primary lipid disrupting myelinopathy. Issue 2 (25th October 2017) Authors: Plemel, Jason R.; Michaels, Nathan J.; Weishaupt, Nina; Caprariello, Andrew V.; Keough, Michael B.; Rogers, James A.; Yukseloglu, Aran; Lim, Jaehyun; Patel, Vikas V.; Rawji, Khalil S.; Jensen, Samuel K.; Teo, Wulin; Heyne, Belinda; Whitehead, Shawn N.; Stys, Peter K.; Yong, V. Wee Journal: Glia Issue: Volume 66:Issue 2(2018) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quantifying the intensity of adverse events with ibuprofen and oxycodone: an observational cohort study. Issue 1 (24th May 2022) Authors: Ali, Samina; Gourlay, Katie; Yukseloglu, Aran; Rosychuk, Rhonda J; Ortiz, Silvia; Watts, Rick; Johnson, David W; Carleton, Bruce; Le May, Sylvie; Drendel, Amy L Journal: BMJ paediatrics open Issue: Volume 6:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗